Skip to main content
Log in

Anagrelide/bisoprolol

Various toxicities and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Sugawara M, et al. Anagrelide-associated Cardiomyopathy and Heart Failure in a Patient with Essential Thrombocythemia: A Case Report and Literature Review. [Review]. Internal Medicine 61: 3293-3299, No. 21, Nov 2022. Available from: URL: http://doi.org/10.2169/internalmedicine.9090-21

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anagrelide/bisoprolol. Reactions Weekly 1935, 41 (2022). https://doi.org/10.1007/s40278-022-28836-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28836-5

Navigation